SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Hematologi) ;pers:(Hasle Henrik)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Hematologi) > Hasle Henrik

  • Resultat 1-10 av 45
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Bager, Ninna, et al. (författare)
  • Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia : A NOPHO-DBH-AML study
  • 2018
  • Ingår i: British Journal of Haematology. - : Wiley. - 0007-1048 .- 1365-2141. ; 183:4, s. 618-628
  • Tidskriftsartikel (refereegranskat)abstract
    • Data on occurrence, genetic characteristics and prognostic impact of complex and monosomal karyotype (CK/MK) in children with acute myeloid leukaemia (AML) are scarce. We studied CK and MK in a large unselected cohort of childhood AML patients diagnosed and treated according to Nordic Society for Paediatric Haematology and Oncology (NOPHO)-AML protocols 1993-2015. In total, 800 patients with de novo AML were included. CK was found in 122 (15%) and MK in 41 (5%) patients. CK and MK patients were young (median age 2.1 and 3.3 years, respectively) and frequently had FAB M7 morphology (24% and 22%, respectively). Refractory disease was more common in MK patients (15% vs. 4%) and stem cell transplantation in first complete remission was more frequent (32% vs. 19%) compared with non-CK/non-MK patients. CK showed no association with refractory disease but was an independent predictor of an inferior event-free survival (EFS; hazard ratio [HR] 1.43, P = 0.03) and overall survival (OS; HR 1.48, P = 0.01). MK was associated with a poor EFS (HR 1.57, P = 0.03) but did not show an inferior OS compared to non-MK patients (HR 1.14, P = 0.62). In a large paediatric cohort, we characterized AML with non-recurrent abnormal karyotype and unravelled the adverse impact of CK and MK on prognosis.
  •  
5.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Klein, Kim, et al. (författare)
  • Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin-Frankfürt-Münster (I-BFM) study group.
  • 2018
  • Ingår i: British journal of haematology. - : Wiley. - 1365-2141 .- 0007-1048. ; 183:1, s. 87-95
  • Tidskriftsartikel (refereegranskat)abstract
    • Prevention of infections is of obvious relevance in paediatric patients with acute myeloid leukaemia (AML). However, recommendations are often non-specific and supported by low-quality evidence, resulting in divergent infection preventive regimens. Using a web-based survey, we investigated the infection prophylaxis guidelines of 22 paediatric AML study groups affiliated to the international Berlin-Frankfürt-Münster study group. In order to evaluate differences in daily practice among hospitals, representatives (n=27) from the Nordic Society for Paediatric Haematology and Oncology-Dutch-Belgium-Hong Kong - AML study group participated in a slightly modified survey. Seven study groups (32%) advise gram-negative antibiotic prophylaxis, mainly with fluoroquinolones (n=6). Gram-positive prophylaxis is prescribed by eight groups (36%). Over 60% of the study groups prescribe food and social restrictions, but the specific topics and strictness differ widely. According to the hospital-based survey, sites roughly comply with common study group guidelines. However, the use of any gram-negative antibiotic prophylaxis, the specific prophylactic antifungal agent and the strictness of the food and social restrictions differ substantially between the hospitals. Despite a long history of close collaboration, many differences are still present between the affiliated groups. The results of this survey provide an appropriate baseline measure to study the emergence and impact of future guidelines on infection prophylaxis in paediatric AML.
  •  
10.
  • Lohmann, Ditte J. A., et al. (författare)
  • Effect of age and body weight on toxicity and sur vival in pediatric acute myeloid leukemia : results from NOPHO-AML 2004
  • 2016
  • Ingår i: Haematologica. - : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 101:11, s. 1359-1367
  • Tidskriftsartikel (refereegranskat)abstract
    • Treatment for pediatric acute myeloid leukemia is very toxic and the association between outcome and age and Body Mass Index is unclear. We investigated effect of age and Body Mass Index on toxicity and survival in pediatric acute myeloid leukemia. We studied all patients who completed first induction course of NOPHO-AML 2004 (n= 318). Toxicity following induction and consolidation courses (n= 6) was analyzed. The probabilities of toxicity and death were determined using time-to-event analyses with Cox multivariate proportional hazard regression for comparative analyses. Age 10-17 years was associated with sepsis with hypotension [hazard ratio 2.3 (95% confidence interval 1.1-4.6)]. Being overweight (> 1 standard deviation) was associated with requiring supplemental oxygen [1.9 (1.0-3.5)]. The 5-year event-free and overall survival were 47% and 71%. Children aged 10-17 years showed a trend for inferior 5-year overall survival compared to children aged 29 (64% vs. 76%; P= 0.07). Infants showed a trend for superior 5-year event-free survival (66% vs. 43%; P= 0.06). Overweight children aged 10-17 years showed a trend for superior survival [5-year event-free survival 59% vs. 40% (P= 0.09) and 5-year overall survival 78% vs. 56% (P= 0.06)] compared to healthy weight children aged 10-17 years. In conclusion, children aged 10-17 years and overweight children had a higher risk of grade 3-4 toxicity. Children aged 10-17 years showed inferior survival, but, unexpectedly, in this age group overweight children tended to have increased survival. This suggests different pharmacokinetics of chemotherapeutic drugs in adolescents and warrants further studies.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 45
Typ av publikation
tidskriftsartikel (30)
konferensbidrag (14)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (37)
övrigt vetenskapligt/konstnärligt (8)
Författare/redaktör
Zeller, Bernward (27)
Abrahamsson, Jonas, ... (25)
Lausen, Birgitte (21)
Jahnukainen, Kirsi (21)
Forestier, Erik (19)
visa fler...
Palle, Josefine (15)
Jonsson, Olafur G. (14)
De Moerloose, Barbar ... (13)
Abrahamsson, Jonas (12)
Ha, Shau-Yin (12)
Heldrup, Jesper (9)
Palle, Josefine, 196 ... (8)
Noren-Nyström, Ulrik ... (8)
Kjeldsen, Eigil (7)
Gustafsson, Göran (6)
Kaspers, Gertjan J. ... (6)
Koskenvuo, Minna (6)
Jonmundsson, Gudmund ... (5)
Saks, Kadri (5)
Hovi, Liisa (4)
Clausen, Niels (4)
Johansson, Bertil (4)
Kaspers, GJ (4)
Arad-Cohen, Nira (4)
Jonsson, OG (3)
Palmqvist, Lars, 196 ... (3)
Jonsson, Olafur Gisl ... (3)
Hovland, Randi (3)
Staffas, Anna, 1982 (3)
Kovalova, Zhanna (3)
Raimondi, Susana C (3)
Larsson, Rolf (2)
Asdahl, Peter H. (2)
Rosenquist, Richard (2)
Winiarski, Jacek (2)
Kanduri, Meena, 1974 (2)
Fogelstrand, Linda, ... (2)
Ehrencrona, Hans (2)
Holmfeldt, Linda (2)
Pieters, Rob (2)
Tomizawa, D (2)
Cheuk, Daniel (2)
Munthe-Kaas, Monica (2)
Pasauliene, Ramune (2)
Bager, Ninna (2)
Juul-Dam, Kristian L ... (2)
Sandahl, Julie D. (2)
Juul-Dam, KL (2)
Sandahl, JD (2)
visa färre...
Lärosäte
Göteborgs universitet (25)
Uppsala universitet (20)
Umeå universitet (17)
Lunds universitet (13)
Karolinska Institutet (8)
Språk
Engelska (45)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (45)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy